Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Vivos Therapeutics (VVOS) Preferred Shares Issued (2020)

Vivos Therapeutics' Preferred Shares Issued history spans 1 years, with the latest figure at $349501.0 for Q4 2020.

  • Quarterly results put Preferred Shares Issued at $349501.0 for Q4 2020, changed N/A from a year ago — trailing twelve months through Dec 2020 was $2.5 million (changed N/A YoY), and the annual figure for FY2020 was $2.5 million, changed.
  • Preferred Shares Issued for Q4 2020 was $349501.0 at Vivos Therapeutics, down from $1.9 million in the prior quarter.
  • In the past five years, Preferred Shares Issued ranged from a high of $1.9 million in Q3 2020 to a low of $200.0 in Q2 2020.